Seattle — Concord Technologies, a leader in healthcare data exchange, interoperability and intelligent document processing, will convene healthcare leaders on the HIMSS 2026 main stage for a high-profile panel discussion on interoperability, moderated by the American Hospital Association.
Titled Rethinking Interoperability: Is It Time to Trust LLMs over Standards?, the session will take place Tuesday, March 10, from 2:40–3:10 p.m. at the HIMSS Global Health Conference in Las Vegas. Moderated by Suzanna Hoppszallern, Senior Editor of Data and Research at the American Hospital Association (AHA), the discussion will bring together provider and technology leaders to examine whether artificial intelligence — particularly large language models (LLMs) — represents a meaningful breakthrough in healthcare data exchange.
Despite decades of policy mandates, interoperability frameworks, and the adoption of standards such as HL7 and FHIR, true interoperability remains elusive. Fragmented systems, vendor constraints, regulatory complexity, and legacy infrastructure continue to hinder seamless data exchange.
Ad Statistics
Times Displayed: 357603
Times Visited: 21085 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
New national survey findings reinforce this gap: while most healthcare leaders view interoperability as vital, nearly half report only moderate interoperability today, and one in four say their organizations remain at a minimal level.
To help ground the discussion in real-world executive perspectives, Concord Technologies has launched a brief, three-minute national survey of healthcare leaders. Insights gathered from CIOs, CMIOs, IT executives, clinicians, and innovators will inform the panel conversation and be synthesized into an AHA/Concord Market Scan report distributed to healthcare leaders nationwide.
As AI capabilities rapidly advance, healthcare leaders are increasingly asking whether a fundamentally different technological approach is required. Survey respondents express cautious optimism about AI’s role in interoperability, with nearly two thirds believing it can accelerate progress, while others remain uncertain or skeptical, underscoring why this debate is both timely and necessary.
The HIMSS main stage session will provide a live, interactive forum for this critical industry discussion. Attendees will have the opportunity to participate in this survey and hear candid perspectives from provider and technology executives on:
• Why interoperability challenges persist after years of standards-based efforts
